The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final report of a phase I/II study of veliparib (Vel) in combination with 5-FU and oxaliplatin (FOLFOX) in patients (pts) with metastatic pancreatic cancer (mPDAC).
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Merrimack; Sirtex Medical
Consulting or Advisory Role - ARMO BioSciences; AstraZeneca/MedImmune; Caris Life Sciences; Celgene; Ignyta; Merck; Perthera; Rafael Pharmaceuticals; RenovoRx; Sirtex Medical
Research Funding - ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Caris Life Sciences; Perthera; Sirtex Medical
 
Hongkun Wang
No Relationships to Disclose
 
Sarah Parenti
No Relationships to Disclose
 
Aiwu Ruth He
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Genentech; Merck
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Regeneron
 
Jimmy J. Hwang
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Centers of Excellence; Eisai; Genentech/Roche; Ipsen; Lilly; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Genentech/Roche; Ipsen
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Lisa Ley
No Relationships to Disclose
 
Holly Difebo
No Relationships to Disclose
 
Brandon George Smaglo
Speakers' Bureau - Taiho Pharmaceutical
 
Sunnie S. Kim
Speakers' Bureau - Merck
 
Benjamin Adam Weinberg
Honoraria - Onclive; Tempus
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Isofol Medical (Inst); Novartis
Travel, Accommodations, Expenses - Caris Life Sciences
 
Louis M. Weiner
Stock and Other Ownership Interests - Celldex; CytomX Therapeutics; Jounce Therapeutics; Merrimack
Consulting or Advisory Role - CytomX Therapeutics; Immunome; Jounce Therapeutics; Merrimack; Novartis
Research Funding - Symphogen
Patents, Royalties, Other Intellectual Property - Patent licensed to Merrimack Pharmaceuticals
Expert Testimony - Abbvie
 
John Marshall
Employment - Caris Life Sciences
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)
 
Jonathan Robert Brody
Consulting or Advisory Role - Perthera
Travel, Accommodations, Expenses - Perthera